ptns update breda
Post on 02-Jul-2015
180 Views
Preview:
DESCRIPTION
TRANSCRIPT
PTNS - update
MRVANBALKEN
5 NOV 2013
5 NOV 2013
5 NOV 2013
5 NOV 2013
5 NOV 2013
12 wekelijkse sessies
elke 2 weken
elke 3 weken
elke 4 weken
hellip
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
5 NOV 2013
5 NOV 2013
12 wekelijkse sessies
elke 2 weken
elke 3 weken
elke 4 weken
hellip
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
5 NOV 2013
12 wekelijkse sessies
elke 2 weken
elke 3 weken
elke 4 weken
hellip
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
12 wekelijkse sessies
elke 2 weken
elke 3 weken
elke 4 weken
hellip
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
12 wekelijkse sessies
elke 2 weken
elke 3 weken
elke 4 weken
hellip
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
PTNS-schema
PTNS 1 of beide benen
PTNS-stimulatieparameters
PTNS-indicaties
PTNS bij neurogeen blaaslijden
PTNS bij instabiliteiten
PTNS en andere behandelingen
PTNS-toekomst
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
5 NOV 2013
Neurourol Urodyn 2013 Jun32(5)472-5 doi 101002nau22322 Epub 2012 Oct 15
Urgent-SQ implant in treatment of overactive bladder syndrome 9-year follow-up study
Janssen DA Farag F Heesakkers JPSource
Department of Urology Radboud University Nijmegen Medical Centre Geert Grooteplein Zuid Nijmegen
The Netherlands djanssenuroumcnnl
Abstract
AIMS
Electrical stimulation of the posterior tibial nerve (PTN) is an established therapy for the treatment of
refractory overactive bladder syndrome (OAB) The Urgent-SQtrade is an implant that is surgically placed near
the PTN and activated by an external pulse generator allowing for on demand PTN stimulation without the
need for needle insertion The current study presents results of a 9-year open-label follow-up of eight
patients to address the long term safety and efficacy of the implant
METHODS
In 2003 eight patients with refractory OAB received a Urgent-SQtrade implant and were systematically followed
up for 1 year After that the follow up continued as open-label study The seven patients who still had the
implant were contacted after 9 years and evaluated with an interview physical exam ankle X-ray voiding
diaries and completed questionnaires about adverse events performance efficacy safety and quality of life
(validated iQoL)
RESULTS
Six of the seven patients still had sensory and loco-motor responses on stimulation at 9-year follow-up
Three of four patients who had a successful treatment response at 1 year still use the device The fourth
patient restarted therapy The implants are intact with no migration andor displacement All patients reported
easy handling of the Urgent-SQtrade One patient reported sporadic spontaneous sensory responses One
patient reported occasional localized ankle discomfort
CONCLUSIONS
After 9 years of clinical experience we demonstrated that implant driven PTNS with the Urgent-SQtrade is a
safe therapy for OAB The implant has a long lifespan and is well tolerated by patients
top related